Latest Posts
About This Stock
More About This Stock
Read
Read
Read
Week In Review: InnoCare Prices Hong Kong IPO To Raise $288 Million
Article By:
ChinaBio® Today
Sunday, March 22, 2020 12:39 PM EDT
InnoCare Pharma of Beijing priced its Hong Kong IPO at the top end of its proposed range to raise $288 million at a $1 billion valuation, according to insiders. The company develops immunotherapies for cancer and autoimmune diseases.
Week In Review: China's I-Mab Stages $104 Million Nasdaq IPO
Article By:
ChinaBio® Today
Saturday, January 18, 2020 2:34 PM EDT
I-Mab, a Shanghai biotech, raised $104 million in its IPO on the Nasdaq exchange to support its portfolio of biologic products.The offering was priced at $14 per ADS but the price has moved 10% lower to $12.58 in initial trading.
Morning Call For May 3, 2016
Article By:
Jim Van Meerten
Tuesday, May 3, 2016 9:21 AM EDT
Jun E-mini S&Ps (ESM16 -0.63%) are down -0.81% and European stocks are down -1.83% at a 2-1/2 week low on global growth concerns after the European Commission cut its Eurozone growth estimates for this year and next.